Design Therapeutics Inc. (NASDAQ: DSGN) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT DESIGN THERAPEUTICS INC.

Design Therapeutics Inc. (NASDAQ: DSGN)
Listen to this Section


$10.74
-0.0210 ( -0.20% ) 398.6K

Design Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the research and development of GeneTACTM molecules, which are a novel class of small-molecule gene-targeted chimera therapeutic candidates designed to be disease-modifying by addressing the underlying cause of diseases caused by inherited nucleotide repeat expansion mutations. The Company's product candidate is in Friedreich ataxia (FA), its second product candidate is in Fuchs endothelial corneal dystrophy (FECD), and it is also advancing its GeneTACTM program to address other serious nucleotide repeat-driven monogenic diseases.

Clinical Trial Pipeline Stages


Drug Name Stage
DT-216DetailsFriedreich’s Ataxia Phase 1
DT-168DetailsFuchs Endothelial Corneal Dystrophy , Eye disease Phase 1

Market Data


Open $10.74
Previous Close $10.76
Volume 398.6K
Market Cap $652.05M
Day Range $10.50 - $10.95
52 Week Range $3.33 - $17.25
Shares Outstanding 62.46M
Change % -0.20%
Net Change ▼ -0.0210
Insider Ownership -0.18%
Exchange NASDAQ
SectorHealthcare
IndustryBiotechnology: Pharmaceutical Preparations
IPO Year2021
CountryUnited States
UnderwriterIPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: -2,289,604.00

Date Type Amount Purchased Purchaser
2024-08-12 Sale -814874.00 William Arsani
2024-06-17 Sale -19000.00 George Simeon
2024-06-17 Sale -19000.00 William Arsani
2024-06-17 Sale -19000.00 Schmid John P.
2024-06-17 Sale -19000.00 LAPPE RODNEY W
2024-06-17 Sale -19000.00 Berger Heather A.
2024-06-17 Sale -19000.00 Prasad Deepa
2024-03-25 Buy 1300.00 Berger Heather A.
2024-03-25 Buy 9156.00 Schmid John P.
2024-01-05 Sale -350000.00 Jeffries Sean

SEC Filings


Form Type Description Pages Date
144 Insider transactions 1 Nov 14, 2025
schedule Other 3 Nov 12, 2025
144 Insider transactions 1 Nov 07, 2025
8-k 8K-related 12 Nov 05, 2025
10-q Quarterly Reports 64 Nov 05, 2025
8-k 8K-related 10 Sep 10, 2025
3 Insider transactions 2 Sep 10, 2025
4 Insider transactions 1 Sep 10, 2025
4 Insider transactions 1 Aug 14, 2025
8-k 8K-related 55 Aug 07, 2025

Latest News


× Before browsing our site, please accept our cookies policy